Early-onset Obesity and Cognitive Impairment in Children With Pseudohypoparathyroidism
2 other identifiers
observational
39
1 country
1
Brief Summary
Pseudohypoparathyroidism type 1a (PHP1a) is a rare disease that causes childhood obesity and learning difficulties. This study will investigate eating behaviors and perform cognitive testing on children with PHP1a. The investigators will compare their results to those of healthy siblings and other obese children.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2014
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2014
CompletedFirst Submitted
Initial submission to the registry
February 25, 2015
CompletedFirst Posted
Study publicly available on registry
April 8, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2017
CompletedResults Posted
Study results publicly available
June 8, 2018
CompletedNovember 13, 2019
October 1, 2019
2.1 years
February 25, 2015
February 28, 2018
October 30, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Intelligence Quotient
Intelligence quotient as measured by Kaufman Brief Intelligence Test, 2nd Edition. This scale yields standard scores where the mean is 100 and one standard deviation is 15. Higher scores indicate better function.
one day
Study Arms (3)
Pseudohypoparathyroidism type 1a
Study group
Healthy siblings
Control group
Obese patients
Control group
Eligibility Criteria
Children with pseudohypoparathyroidism type 1a (PHP1a), their healthy siblings and matched obese controls
You may qualify if:
- Clinical diagnosis of PHP1a, sibling of a patient with PHP1a or matched obese control
You may not qualify if:
- Treatment with appetite-altering drug or initiation of a new weight loss program in the past 3 months
- Type 2 diabetes
- Obesity due to a genetic syndrome, growth hormone deficiency, untreated hypothyroidism, Cushing syndrome or exogenous glucocorticoid administration
- Weight loss greater than 10% over the previous 6 months
- Autism or other significant learning disorder
- Type 2 diabetes
- Other significant medical condition
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Vanderbilt University
Nashville, Tennessee, 37232, United States
Related Publications (4)
Shoemaker AH, Lomenick JP, Saville BR, Wang W, Buchowski MS, Cone RD. Energy expenditure in obese children with pseudohypoparathyroidism type 1a. Int J Obes (Lond). 2013 Aug;37(8):1147-53. doi: 10.1038/ijo.2012.200. Epub 2012 Dec 11.
PMID: 23229731BACKGROUNDWang L, Shoemaker AH. Eating behaviors in obese children with pseudohypoparathyroidism type 1a: a cross-sectional study. Int J Pediatr Endocrinol. 2014;2014(1):21. doi: 10.1186/1687-9856-2014-21. Epub 2014 Oct 15.
PMID: 25337124BACKGROUNDLandreth H, Malow BA, Shoemaker AH. Increased Prevalence of Sleep Apnea in Children with Pseudohypoparathyroidism Type 1a. Horm Res Paediatr. 2015;84(1):1-5. doi: 10.1159/000381452. Epub 2015 Apr 23.
PMID: 25925491BACKGROUNDPerez KM, Lee EB, Kahanda S, Duis J, Reyes M, Juppner H, Shoemaker AH. Cognitive and behavioral phenotype of children with pseudohypoparathyroidism type 1A. Am J Med Genet A. 2018 Feb;176(2):283-289. doi: 10.1002/ajmg.a.38534. Epub 2017 Nov 28.
PMID: 29193623BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Ashley Shoemaker, Principal Investigator
- Organization
- Vanderbilt University Medical Center
Study Officials
- PRINCIPAL INVESTIGATOR
Ashley Shoemaker, MD
Vanderbilt University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Pediatrics, Pediatric Endocrinology and Diabetes
Study Record Dates
First Submitted
February 25, 2015
First Posted
April 8, 2015
Study Start
December 1, 2014
Primary Completion
January 1, 2017
Study Completion
January 1, 2017
Last Updated
November 13, 2019
Results First Posted
June 8, 2018
Record last verified: 2019-10
Data Sharing
- IPD Sharing
- Will not share